Moderna Touts mRNA Progress, Plus $750m From Blackstone To Back Its Flu Vaccine

 
• By Joseph Haas
  
COVID-19 vaccine
Moderna's next-gen COVID-19 vaccine shows better immune response than SpikeVax • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D